Pulmonology: Clinical Research Program

Pulmonology: Clinical Studies Open For Enrollment

• A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants with Severe Asthma including Several Under-Studied Populations in the United States (PASSAGE).
• Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
  

 

A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants with Severe Asthma including Several Under-Studied Populations in the United States (PASSAGE).

Eligibility

• 12 years of age or older
• Asthma diagnosis for at least past 12 months
• Use of medium to high dose inhaled corticosteroids for at least 12 months as well as an additional asthma maintenance controller
• Two or more asthma exacerbations in the past 12 months
• Not using biologics in the past four months
• No severe COPD
  

Enrollment Status: Enrolling

Study Information

ClinicalTrials.gov | NCT05329194

Principal Investigator

Dr. Sankaran Krishnan

Contact for Study Screening

rwilliam11@nymc.edu

 

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)

Eligibility

• Diagnosis of Cystic Fibrosis
• No history of transplant
• No exacerbations in past two weeks
  

Enrollment Status: Enrolling

Study Information

ClinicalTrials.gov | NCT05639556

Principal Investigator

Dr.Allen Dozer

Contact for Study Screening

rwilliam11@nymc.edu